Assessment of the Influence of Cleft Repair on Microcirculation of the Palate
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Mar 14, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how surgery for cleft lip and palate affects blood flow in the palate, which is the roof of the mouth. Researchers want to understand if repairing these clefts improves the circulation in the tissue, as good blood flow is important for healing and overall health.
The trial is open to patients aged 18 to 39 who have orofacial clefts and are scheduled for routine surgery to repair these conditions. Participants will undergo a simple, non-invasive procedure to measure blood flow in the palate before and after their surgery. It’s important to note that individuals who do not have complete data or who do not give permission for their information to be used in the research will not be included. This study could help improve our understanding of how cleft repair impacts healing, which may benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with orofacial clefts, who undergo routine cleft repair
- Exclusion Criteria:
- • missing datasets
- • no signed consent for research.
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Benito K Benitez, MD DDS MHBA
Principal Investigator
University Basel and University Hospital Basel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials